Karolinska Development AB (publ) org. nr. 556707-5048 Registered office: Solna © Karolinska Development 2008
News
2008-11-25 Atherosclerosis vaccine study wins VINNOVA grant 2008-11-20 Strong start to sales of Karolinska Development's New Share Issue 2008-11-13 Karolinska Development Strengthens its Management Team with the Appointment of Dr Carl Harald Janson 2008-11-05 BioCis Pharma Begins Phase IIa Trial in Atopic Dermatitis 2008-11-03 Invitation to Invest 2008-10-02 Xalieve™ Gains Momentum as Calabar AB Launches a Phase II Repeated Dose Study in Dry Mouth Patients 2008-10-02 Athera Biotechnologies and Dyax Announce a Collaboration to Discover and Develop Antibodies for Cardiovascular Inflammation 2008-09-09 BioCis Pharma Receives 1.6 Million EURO New Financing to Speed the Clinical Phase I/II Programme of the Company’s Dermatology Product. 2008-09-01 Calabar AB today announced new financing for continuation of the phase II program in patients with dry mouth 2008-07-29 Athera Biotechnology Founder Johan Frostegard and His Colleagues Win Distinguished Abstract Award 2008-06-17 Dr. Conny Bogentoft will be Presenting ‘Technology Transfer at the Karolinska Institutet’ at Bio2008 2008-06-17 Axelar Initiates Phase I/II Clinical Trial on Cancer Patients With the New Anti-Cancer Drug AXL1717 2008-06-12 Axelar Receives Financing For A Phase I/II Clinical Trial On Cancer Patients 2008-05-26 Strong VC-trio Invest in PharmaSurgics Wound Healing Product 2008-06-11 Annual General Meeting of Karolinska Development AB (publ) 2008-04-02 DermaGen AB Receives Over 1 million Euros From a New Share Issue 2008-04-04 IMED licenses technology from Medarex for fully human monoclonal antibodies 2008-03-04 BioCis Pharma has initiated a first-in-man study with ProtoCure™ emulsion cream 2008-05-01 Karolinska Development – an important new player in nordic life science 2008-02-05 Karolinska Institutet and Karolinska Development AB
---